Unichem Laboratories Limited, commonly referred to as Unichem, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1944, the company has made significant strides in developing and manufacturing a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, Unichem operates in key regions such as North America, Europe, and Asia. The company is renowned for its commitment to quality and innovation, offering unique products that cater to various therapeutic segments, including cardiology, psychiatry, and anti-infectives. Unichem's dedication to research and development has positioned it as a trusted name in the industry, achieving notable milestones such as successful product registrations and strategic partnerships. With a robust portfolio and a focus on sustainable growth, Unichem Laboratories continues to enhance its market position as a leader in the pharmaceutical sector.
How does Unichem Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Unichem Laboratories's score of 24 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2025, Unichem Laboratories reported total carbon emissions of approximately 10,405,000 kg CO2e for Scope 1 and about 59,689,000 kg CO2e for Scope 2. This reflects a significant commitment to transparency in their climate impact, although no Scope 3 emissions data has been disclosed. Comparatively, in 2024, the company recorded Scope 1 emissions of about 13,842,000 kg CO2e and Scope 2 emissions of approximately 74,188,000 kg CO2e. The 2023 figures were similar, with Scope 1 emissions at about 13,842,000 kg CO2e and Scope 2 emissions at around 74,188,000 kg CO2e. In 2022, emissions were higher, with Scope 1 at approximately 22,444,000 kg CO2e and Scope 2 at about 66,589,000 kg CO2e. Despite these figures, Unichem Laboratories has not set specific reduction targets or climate pledges, as indicated by the absence of documented reduction initiatives. The emissions data is cascaded from their parent company, Ipca Laboratories Limited, reflecting a corporate family relationship that influences their reporting and sustainability strategies. Overall, while Unichem Laboratories demonstrates a commitment to monitoring and reporting emissions, further clarity on reduction targets and initiatives would enhance their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Scope 1 | 22,444,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 66,589,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Unichem Laboratories has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.